Applied Genetic Technologies (AGTC) Reports Q1 Loss, Misses Revenue Estimates
Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of -17.65% and -100.00%, respectively, for the quarter ended September 2020.…
Börse:
4,536$
-1,18%
Echtzeit-Aktienkurs Applied Genetic Technologies Corp
Bid:
4,467$
Ask:
4,605$
Nachrichten zur Applied Genetic Technologies Corp Aktie
APPLIED GENETIC TECHNOLOGIES CORP: 10-Q Report
10-Q...…
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2020
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a…
Interim data on gene therapy for vision loss disorder fails to lift Applied Genetic
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
APPLIED GENETIC TECHNOLOGIES CORP: 10-K Report
10-K...…
Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q4 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Intra-Cellular Therapies, Trillium Therapeutics leads gainers, Co-Diagnostics, Applied Genetic Technologies among losers
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Applied Genetic Technologies Corporation 2020 Q4 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AGTC to Participate at Upcoming Virtual Investor Conferences
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a…
AGTC Abuzz, AMRN Slumps & CORT Soars As Oral Arguments Commence, FLGT Gears Up, NNVC On Watch
Todays Daily Dose brings you news about Applied Genetics upcoming presentation, oral arguments in patent suits of Amarin and Corcept,…
Applied Genetic Technologies (AGTC) Presents At Wedbush Pacgrow Healthcare Virtual Conference - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Applied Genetic Tech to expand study of gene therapy for vision loss disorder
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Applied Genetic Tech up 9% on potential takeover interest
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Is Applied Genetic Technologies (AGTC) Stock Outpacing Its Medical Peers This Year?
Is (AGTC) Outperforming Other Medical Stocks This Year?...…
Is Applied Genetic Technologies (AGTC) Outperforming Other Medical Stocks This Year?
Is (AGTC) Outperforming Other Medical Stocks This Year?...…
Applied Genetic Reports Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q3 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Applied Genetic Technologies (AGTC) Reports Q3 Loss, Misses Revenue Estimates
Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of 9.09% and -100.00%, respectively, for the quarter ended March 2020.…
Applied Genetic Technologies Corporation 2020 Q3 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Applied Genetic EPS beats by $0.05
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Applied Genetic Technologies Shares March Higher, Can It Continue-
As of late, it has definitely been a great time to be an investor in Applied Genetic Technologies....…
Applied Genetic Technologies (AGTC) Investor Presentation - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
All You Need to Know About Applied Genetic Technologies (AGTC) Rating Upgrade to Buy
Applied Genetic Technologies (AGTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade…
Applied Genetic Tech down 7% premarket after pricing equity offering
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AGTC Announces Pricing of $32,500,000 Public Offering of Common Stock
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a…
The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks…
Applied Genetic Tech down 12% after hours on equity offering
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AGTC Announces Proposed Public Offering of Common Stock
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a…
Exclusive: Applied Genetics CEO Talks Partnerships, Politics, Pipeline
In the last year, sell-side analysts have shown confidence in Applied Genetic Technologies Corp (NASDAQ: AGTC) with a series of…
Applied Genetic Slumps Despite Encouraging Data For Gene Therapy To Treat Rare Inherited Visual Disorder
Shares of Applied Genetic Technologies Corp (NASDAQ: AGTC) are tumbling Thursday despite the company reporting encouraging results from an Phase…
Applied Genetic Tech down 31% premarket on "encouraging" gene therapy data
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
CNCE Hits Right Notes, BXRX Faces FDA In Feb., All Eyes On AGTC
Todays Daily Dose brings you news about Akceas promising trial results of antisense drug AKCEA-APOCIII-LRx, Applied Genetics upcoming event, the…
AGTC to Host Conference Call and Webcast on January 23 at 8:00 am ET to Discuss Achromatopsia Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a…